Edit |   |
Antigenic Specificity | EGFR, Human (Nimotuzumab biosimilar) |
Clone | Nimotuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IP, FCM, FuncS, Neut, IF, IHC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human EGFR Recombinant Antibody (Nimotuzumab). Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India, TheraCIM, CIMYM Biosciences, Canada, Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials. |
Immunogen | n/a |
Other Names | Anti-EGFR Recombinant Antibody, Research Grade Nimotuzumab, Anti-Human EGFR Recombinant Antibody(Nimotuzumab), Theraloc, hR3, Antibody Drug Analogues, Monoclonal Antibody, YR1033, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 828933-51-3 |
Catalog # | YR1033 |
Price | please inquire |
Order / More Info | EGFR, Human (Nimotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |